A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Adult Participants · Hepatic Impairment (HI)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
Contact: Study coordinator (Huan Zhou) · zhouhuanbest@vip.163.com · +86 0552-3085747

Study leads

Huan Zhou
Principal Investigator
The First Affiliated Hospital of Bengbu Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

Renal Impairment · Healthy

Abroad (travel likely)RecruitingPHASE1

Lake Forest, United States · Orlando, United States

A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Seoul, South Korea

A Phase 1 Study of BLKR201 in Healthy Adult Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Lincoln, United States

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

C3 Glomerulopathy (C3G) · Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Vienna, Austria · Brussels, Belgium